ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” fourth ...

The equity markets have been volatile due to factors like US trade tariffs, FPI selling, and slowing GDP growth. Large-cap ...

We recently published a list of 10 Best Blue Chip Stocks to Buy for 2025. In this article, we are going to take a look at ...

We recently published a list of 10 Best Blue Chip Stocks to Buy for 2025. In this article, we are going to take a look at ...

Each month in PWM, nine top European asset allocators reveal how they would spend €100,000 in a fund supermarket for a fairly ...

With such a wide range of potential outcomes this year, risk management and value capture will be important themes.

Investors are watching to see if technology companies and related heavyweights will add to recent strong profit gains and ...

The biggest US tech stocks have enjoyed an earnings bonanza in the past two years, leading to their significant ...

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.

Heading into the end of the year, the investment market has given us and our clients plenty to be thankful for Even so, more ...